Skip to content
Trial Eligibility
Menu

Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine

NCT05962229

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

In a crossover study, experienced electronic cigarette users will vape 3 different forms of nicotine: natural (derived from tobacco), synthetic, or a 50:50 mixture of both natural and synthetic. The investigators will compare nicotine metabolism, cardiovascular effects, patterns of self-administration, and participants' feelings of craving/withdrawal and enjoyment.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Nicotine Dependence
  • Nicotine Vaping

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
21 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, San Francisco
Last updated on ClinicalTrials.gov
May 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Zuckerberg San Francisco General Hospital (ZSFG) · San Francisco, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.